News Outlets Report On COVID-19 Vaccine, Treatment Research, Development

Bloomberg: Trial Illness Likely Not Linked to Covid Shot, Oxford Says (Paton, 9/16).

New York Times: An Experimental Drug Protects Covid-19 Patients, Eli Lilly Claims (Kolata, 9/16).

STAT: Lilly’s Covid-19 antibody helps some patients rid their systems of virus sooner in early analysis (Herper/Garde, 9/16).

USA TODAY: Pfizer reports ‘potential’ of COVID-19 candidate vaccine after expanding trial to 44,000 people (Weintraub, 9/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.